Impact of Streptococcus pneumoniae in pneumonias of Latin American children;Impacto de Streptococcus pneumoniae en las neumonias del nino latinoamericano. Grupo SIREVA-Vigia

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 8, Issue 3, 2000, Pages 185-195

  Hortal, María ^a,b   Ruvinsky, Raúl ^c   Rossi, Alicia ^d   Agudelo, Clara I ^e   Castañeda, Elizabeth ^e   Brandileone, Cristina ^f   Camou, Teresa ^a   Palacio, Rosario ^a   Echaniz, Gabriela ^g   Di Fabio, José L ^h  

^a Centro Nacional de Referencia de Influenza y otros Virus Respiratorios   (Uruguay)

^b Departamento Laboratorios de Salud ^*  (Uruguay)

^c HOSPITAL DURAND   (Argentina)

^d Instituto Nacional de Microbiologia Dr Carlos GMalbran   (Argentina)

^e INSTITUTO NACIONAL DE SALUD   (Colombia)

^f INSTITUTO ADOLFO LUTZ   (Brazil)

^g INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^h PAN AMERICAN HEALTH ORGANIZATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE; ERYTHROMYCIN; HAEMOPHILUS INFLUENZAE VACCINE; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CENTRAL AMERICA; CHILD; DEVELOPING COUNTRY; FEMALE; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INFANT; INFANT MORTALITY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PNEUMONIA; SEROTYPE; SOUTH AMERICA; STREPTOCOCCUS PNEUMONIAE; SYMPTOM;

EID: 0033815721     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1020-49892000000800006     Document Type: Article

References (59)

1. Potential interventions for the prevention of childhood pneumonia in developing countries: A systematic review
2. Tasas de mortalidad por enfermedades prevalentes en la infancia
3. Etiologia y clinica de la IRA baja adquirida en la comunidad en 100 ninos estudiados a nivel hospitalario
4. Microbial agents associated with pneumonia in children from Uruguay
5. Etiologic and clinical evaluation of acute lower respiratory tract infection in young Argentinian children: An overview
6. Serotypes and antimicrobial susceptibility of Streptococcus pneumoniae isolated in Rio de Janeiro, Brazil
7. The epidemiology of pneumococcal disease in infants and children
8. Introduccion de la vacuna conjugada contra Hib en Chile y Uruguay
9. Rapid diagnosis of pneumonia in children
10. Six newly recognized types of Streptococcus pneumoniae
11. Pan American Health Organization epidemiological surveillance network for Streptococcus pneumoniae
12. Distribution of capsular types and penicillin-resistance of strains of Streptococcus pneumoniae causing systemic infections in Argentinian children under 5 years of age. Streptococcus pneumoniae Working Group
13. Prevalence of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated from Brazilian children with invasive infections. Pneumococcal Study Group in Brazil for the SIREVA Project. Regional System for Vaccines in Latin America
14. Distribution of capsular types and antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Colombian children. Pneumococcal Study Group in Colombia
15. Antimicrobial susceptibilities and capsular types of invasive Streptococcus pneumoniae isolated in children in Mexico City
16. Capsular type distribution and susceptibility to antibiotics of Streptococcus pneumoniae clinical strains isolated from Uruguayan children with systemic infections. Pneumococus study group
17. Invasive Streptococcus pneumoniae infection in Latin American children: Results of the Pan American Health Organization surveillance study
18. El control de las infecciones respiratorias agudas a nivel local
19. Typing of pneumococci by using 12 pooled antisera
20. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines
21. Prospective comparative study of viral, bacterial and atypical organisms identified in pneumonia and bronchiolitis in hospitalized Canadian infants
22. Immunization with a pneumococcal capsular polysaccharide vaccine during pregnancy
23. Neonatal immunization: Response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine
24. Transplacental trasmission of serotype-specific pneumococcal antibodies in a Brazilian population
25. Opsonic activity of commercially available standard intravenous immunoglobulin preparations
26. Vigilancia centinela de IRA de vias bajas por Streptococcus pneumoniae y Haemophilus influenzae. Ministerio de Salud de Colombia, Instituto Nacional de Salud
27. Rapid detection of pneumococcal antigen in pleural fluid of patients with community acquired pneumonia
28. Demonstration of circulating pneumococcal immunoglobulin G immune complexes in patients with community-acquired pneumonia by means of an enzyme-linked immunosorbent assay
29. Serologically indicated pneumococcal respiratory infection in children
30. Diagnosis of bacteremic pneumococcal pneumonia by amplification of pneumolysin gene fragment in serum
31. Pneumococcal polysaccharide vaccines
32. Pneumococcal vaccine
33. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants
34. Potential interventions for the prevention of childhood pneumonia: Geographic and temporal differences in serotype and serogroup distribution of sterile site isolates from children: Implications for vaccine strategies
35. Ten-year review of invasive pneumococcal diseases in children and adults from Uruguay: Clinical spectrum, serotypes and anti-microbial resistance
36. Horizontal transfer of multiple penicillin-binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae
37. Carriage of pneumococci after pneumococcal vaccination
38. Monoclonal antibody recognizing a species-specific protein from Streptococcus pneumoniae
39. Pneumococcal virulence factors and host immune responses to them
40. Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice
41. Emerging infectious diseases
42. Resistencia bacteriana y su participacion en la reemergencia de enfermedades: Aspectos microbiologicos
43. El desafio de las enfermedades emergentes y reemergentes
44. Genetics and molecular biology of beta-lactamresistant pneumococci
45. Penicillin-binding protein-mediated resistance in pneumococci and staphylococci
46. High incidence of resistance to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a University hospital in Korea
47. Evolving resistance patterns of Streptococcus pneumoniae: A link with long-acting macrolide consumption?
48. Emergence of drug-resistant pneumococcal infections in the United Satates
49. Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group
50. Molecular epidemiologic characterization of penicillin-resistant Streptococcus pneumoniae invasive pediatric isolates recovered in six Latin-American countries: An overview. PAHO/Rockefeller University Workshop. Pan American Health Organization
51. Determination of trimethoprim-sulfamethoxazole resistance in Streptococcus pneumoniae by using the E test with Mueller-Hinton agar supplemented with sheep or horse blood may be unreliable. The Pneumococcal Study Group
52. Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae
53. Capsular transformation of a multidrug-resistant Streptococcus pneumoniae in vivo
54. Etiology of pneumonia in children
55. Surveillance for penicillin-nonsusceptible Streptococcus pneumoniae, New York City, 1995
56. Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci